A carregar...
Biodistribution and radiation dose estimates for (68)Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors
PURPOSE: Somatostatin receptor antagonists have shown promise for imaging neuroendocrine tumors (NETs) in preclinical studies, but clinical data is still very limited. In this study, we assess the feasibility of using the novel somatostatin antagonist (68)Ga-DOTA-JR11 for PET imaging of NETs. METHOD...
Na minha lista:
| Publicado no: | Eur J Nucl Med Mol Imaging |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6447060/ https://ncbi.nlm.nih.gov/pubmed/30374529 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-018-4193-y |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|